Nutraceuticals Market Size, Share, Opportunities, And Trends By Type (Functional foods, Functional drinks, Dietary supplements, Herbal products), By Application (Food, Food Ingredient, Dietary supplement, Drug), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2025 To 2030

Nutraceuticals Market Size:

The Nutraceuticals Market is expected to grow from USD 587.193 billion in 2025 to USD 859.589 billion in 2030, at a CAGR of 7.92%.

Nutraceuticals Market Trends:

The demand for nutraceuticals (nutrition + pharmaceutical) is increasing on account of their ability to treat or prevent diseases in addition to providing nutrition. These are available in the market in the form of functional food and beverages, and herbal products like ginger, garlic, onion, turmeric, and many more. The growing aging population and growing health concerns worldwide are the major drivers driving the growth of the global nutraceuticals market. Producers term nutraceuticals for what is already available in the market in the form of food, spices, food ingredients, and dietary supplements.

• DRIVERS
o Growing health concerns
o Increasing Incidences of Chronic Diseases

• RESTRAINTS
o High cost involved
o Lack of product awareness

• INDUSTRY UPDATE
o In June 2019, Roquette Introduced PEARLITOL SW-F for Gluten-Free Nutraceuticals Dosage Forms
o In March 2019, Martin Bauer Group Acquired BI Nutraceuticals, which is expected to help the organization broaden its portfolio of ingredients.

The major players profiled in the Nutraceuticals market are Abbott Laboratories, AOR, AjinomotHealth & Nutrition North America, Inc., Archer Daniels Midland Company, Cargill, Danone S.A., Mead Johnson & Company, LLC, Nestlé, Nordic Naturals, and Omega Protein Corporation, among others.                                                 

Nutraceuticals Market Segmentation:

The Nutraceuticals market has been analyzed through the following segments:

• By Type
  • Functional Foods
  • Functional Beverages
  • Dietary supplements
  • Herbal and Natural Products
• By Form
  • Capsules & Tablets
  • Powders
  • Gummies & Chewables
  • Liquids
  • Softgels
  • Bars & Snacks
• By Distribution Channel
  • Online
  • Offline
• By End-User
  • Adults
  • Geriatric Population
  • Children
  • Pregnant Women
  • Athletes
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NUTRACEUTICALS MARKET BY TYPE

5.1. Introduction

5.2. Functional Foods

5.3. Functional Beverages

5.4. Dietary Supplements

5.5. Herbal and Natural Products

6. NUTRACEUTICALS MARKET BY FORM

6.1. Introduction

6.2. Capsules & Tablets

6.3. Powders

6.4. Gummies & Chewables

6.5. Liquids

6.6. Softgels

6.7. Bars & Snacks

7. NUTRACEUTICALS MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Online

7.3. Offline

8. NUTRACEUTICALS MARKET BY END-USER

8.1. Introduction

8.2. Adults

8.3. Geriatric Population

8.4. Children

8.5. Pregnant Women

8.6. Athletes

9. NUTRACEUTICALS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. By Type

9.2.2. By Form

9.2.3. By Distribution Channel

9.2.4. By End-User

9.2.5. By Country

9.2.5.1. USA

9.2.5.2. Canada

9.2.5.3. Mexico

9.3. South America

9.3.1. By Type

9.3.2. By Form

9.3.3. By Distribution Channel

9.3.4. By End-User

9.3.5. By Country

9.3.5.1. Brazil

9.3.5.2. Argentina

9.3.5.3. Others

9.4. Europe

9.4.1. By Type

9.4.2. By Form

9.4.3. By Distribution Channel

9.4.4. By End-User

9.4.5. By Country

9.4.5.1. United Kingdom

9.4.5.2. Germany

9.4.5.3. France

9.4.5.4. Spain

9.4.5.5. Others

9.5. Middle East and Africa

9.5.1. By Type

9.5.2. By Form

9.5.3. By Distribution Channel

9.5.4. By End-User

9.5.5. By Country

9.5.5.1. Saudi Arabia

9.5.5.2. UAE

9.5.5.3. Others

9.6. Asia Pacific

9.6.1. By Type

9.6.2. By Form

9.6.3. By Distribution Channel

9.6.4. By End-User

9.6.5. By Country

9.6.5.1. China

9.6.5.2. Japan

9.6.5.3. South Korea

9.6.5.4. India

9.6.5.5. Indonesia

9.6.5.6. Thailand

9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Abbott Laboratories

11.2. AOR

11.3. Ajinomoto Health & Nutrition North America, Inc.

11.4. Archer Daniels Midland Company

11.5. Cargill, Incorporated

11.6. Danone S.A.

11.7. Mead Johnson & Company, LLC.

11.8. Nestlé

11.9. Nordic Naturals

11.10. Omega Protein Corporation

11.11. DSM-Firmenich (Koninklijke DSM N.V.)

11.12. International Flavors & Fragrances Inc. (IFF)

11.13. GlaxoSmithKline plc.

11.14. Bayer AG

Abbott Laboratories

AOR

Ajinomoto Health & Nutrition North America, Inc.

Archer Daniels Midland Company

Cargill, Incorporated

Danone S.A.

Mead Johnson & Company, LLC.

Nestlé

Nordic Naturals

Omega Protein Corporation

DSM-Firmenich (Koninklijke DSM N.V.)

International Flavors & Fragrances Inc. (IFF)

GlaxoSmithKline plc.

Bayer AG